Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Allogeneic Versus Autologous Platelet-Rich Plasma for Diabetic Wound Healing in Patients With Renal Dysfunction：a Randomized Controlled Trial

NCT07020559 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT07020559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07020559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Allogeneic Versus Autologous Platelet-Rich Plasma for Diabetic Wound Healing in Patients With Renal Dysfunction：a Randomized Controlled Trial
Lead sponsor
Peking University Third Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
May 31, 2028
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic blood transfusions, diabetic wounds, platelet rich plasma, renal dysfunction